Big Gain For Cara Therapeutics, Inc.
Thu, Dec 19, 2024 at 07:10 PM
Cara Therapeutics, Inc. (CARA:NASDAQ) soared at $0.41, representing a gain of 56%. On Thu, Dec 19, 2024, CARA:NASDAQ hit a New 2-Week High of $0.41. The stock got featured on our News Catalysts scanner on Wed, Dec 18, 2024 at 08:21 AM in the 'AGREEMENT' category. From Thu, Dec 05, 2024, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Dec 19, 2024 at $0.52 with a volume of 25M+.
About Cara Therapeutics, Inc. (CARA:NASDAQ)
Cara Therapeutics Inc is an emerging biotechnology company. It is focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors.
Top 10 Gainers:
- PainReform Ltd. (PRFX:NASDAQ), 409.59%
- Nvni Group Limited (NVNI:NASDAQ), 317.19%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 122.72%
- MSP Recovery Inc. (LIFW:NASDAQ), 103.77%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 92.42%
- Trio Petroleum Corp. (TPET:NYSEMKT), 79.16%
- XChange TEC.INC American Depositary Shares (XHG:NASDAQ), 64.56%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 60.78%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 56.25%
- Cara Therapeutics, Inc. (CARA:NASDAQ), 56.01%